help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Molecular Endocrinology, doi:10.1210/me.2007-0399
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Halperin, J.
Right arrow Articles by Gibori, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Halperin, J.
Right arrow Articles by Gibori, G.
Molecular Endocrinology 22 (2): 513-522
Copyright © 2008 by The Endocrine Society

Prolactin Signaling through the Short Form of Its Receptor Represses Forkhead Transcription Factor FOXO3 and Its Target Gene Galt Causing a Severe Ovarian Defect

Julia Halperin, Sangeeta Y. Devi, Shai Elizur, Carlos Stocco, Aurora Shehu, Diane Rebourcet, Terry G. Unterman, Nancy D. Leslie, Jamie Le, Nadine Binart1 and Geula Gibori1

Department of Physiology and Biophysics (J.H., S.Y.D., S.E., C.S., A.S., J.L., G.G.), College of Medicine, and Department of Medicine (T.G.U.), University of Illinois at Chicago, and Jesse Brown Veterans Affairs Medical Center (T.G.U.), Chicago, Illinois 60612; Institut National de la Santé et de la Recherche Médicale U845 (D.R., N.B.), Université Paris-Descartes, Faculté de Médecine René Descartes, Site Necker, Unité Mixte de Recherche S845, Paris F-75015, France; and Division of Human Genetics (N.D.L.), Cincinnati Children’s Hospital Medical Center and University of Cincinnati, Cincinnati, Ohio 45229

Address all correspondence and requests for reprints to Geula Gibori, Ph.D., 835 South Wolcott, M/C 901, Chicago, Illinois 60612. E-mail: ggibori{at}uic.edu.

Prolactin (PRL) is a hormone with over 300 biological activities. Although the signaling pathway downstream of the long form of its receptor (RL) has been well characterized, little is known about PRL actions upon activation of the short form (RS). Here, we show that mice expressing only RS exhibit an ovarian phenotype of accelerated follicular recruitment followed by massive follicular death leading to premature ovarian failure. Consequently, RS-expressing ovaries of young adults are depleted of functional follicles and formed mostly by interstitium. We also show that activation of RS represses the expression of the transcription factor Forkhead box O3 (FOXO3) and that of the enzyme galactose-1-phosphate uridyltransferase (Galt), two proteins known to be essential for normal follicular development. Our finding that FOXO3 regulates the expression of Galt and enhances its transcriptional activity indicates that it is the repression of FOXO3 by PRL acting through RS that prevents Galt expression in the ovary and causes follicular death. Coexpression of RL with RS prevents PRL inhibition of Galt, and the ovarian defect is no longer seen in RS transgenic mice that coexpress RL, suggesting that RL prevents RS-induced ovarian impairment. In summary, we show that PRL signals through RS and causes, in the absence of RL, a severe ovarian pathology by repressing the expression of FOXO3 and that of its target gene Galt. We also provide evidence of a link between the premature ovarian failure seen in mice expressing RS and in mice with FOXO3 gene deletion as well as in human with Galt mutation.




This article has been cited by other articles:


Home page
EndocrinologyHome page
Y. S. Devi, A. Shehu, C. Stocco, J. Halperin, J. Le, A. M. Seibold, M. Lahav, N. Binart, and G. Gibori
Regulation of Transcription Factors and Repression of Sp1 by Prolactin Signaling Through the Short Isoform of Its Cognate Receptor
Endocrinology, July 1, 2009; 150(7): 3327 - 3335.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
R. Shao, M. Nutu, B. Weijdegard, E. Egecioglu, J. Fernandez-Rodriguez, E. Tallet, V. Goffin, C. Ling, and H. Billig
Differences in Prolactin Receptor (PRLR) in Mouse and Human Fallopian Tubes: Evidence for Multiple Regulatory Mechanisms Controlling PRLR Isoform Expression in Mice
Biol Reprod, October 1, 2008; 79(4): 748 - 757.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2008 by The Endocrine Society